Patents by Inventor Sai Chakradhar PADALA

Sai Chakradhar PADALA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VEGFR-FC FUSION PROTEIN FORMULATIONS
    Publication number: 20230025418
    Abstract: VEGFR-Fc fusion protein formulations and methods of making using such formulations are provided herein. In one embodiment, the formulation is an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the VEGFR-Fc fusion protein is aflibercept.
    Type: Application
    Filed: September 14, 2022
    Publication date: January 26, 2023
    Applicant: Amgen Inc.
    Inventors: Yael WEXLER-COHEN, Robert Matthew FESINMEYER, Monica Michelle GOSS, Sekhar KANAPURAM, Rahul Rajan KAUSHIK, Sai Chakradhar PADALA
  • A CONTINUOUS MANUFACTURING PROCESS FOR BIOLOGICS MANUFACTURING BY INTEGRATION OF DRUG SUBSTANCE AND DRUG PRODUCT PROCESSES
    Publication number: 20220119526
    Abstract: A biologics manufacturing process that connects the drug substance and drug product processes into an integrated, continuous process.
    Type: Application
    Filed: January 27, 2020
    Publication date: April 21, 2022
    Applicant: AMGEN INC.
    Inventors: Subramanian GUHAN, Malhar R. AMBHAIKAR, Vincent CHAI, Sai Chakradhar PADALA, Nitin RATHORE, Zane SAREMI, Kenneth SHOEMAKER, Benjamin J. TILLOTSON, Balakumar THANGARAJ, Philip CLARK, Ashish SHARMA, Hann-Chung WONG, John E. THORUP
  • VEGFR-FC FUSION PROTEIN FORMULATIONS
    Publication number: 20200338164
    Abstract: Protein formulations and methods of making and using such formulations are provided herein. The formulation can be an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the formulation comprises a VEGFR-Fc fusion protein, such as aflibercept.
    Type: Application
    Filed: November 16, 2018
    Publication date: October 29, 2020
    Applicant: AMGEN INC.
    Inventors: Yael WEXLER-COHEN, William J. CALLAHAN, Robert Matthew FESINMEYER, Rahul Rajan KAUSHIK, Sai Chakradhar PADALA
  • VEGFR-FC FUSION PROTEIN FORMULATIONS
    Publication number: 20200255496
    Abstract: VEGFR-Fc fusion protein formulations and methods of making using such formulations are provided herein. In one embodiment, the formulation is an ophthalmic formulation, such as for intravitreal administration. In some embodiments, the VEG-FR-Fc fusion protein is aflibercept.
    Type: Application
    Filed: September 17, 2018
    Publication date: August 13, 2020
    Applicant: AMGEN INC.
    Inventors: Yael WEXLER-COHEN, Robert Matthew FESINMEYER, Monica Michelle GOSS, Sekhar KANAPURAM, Rahul Rajan KAUSHIK, Sai Chakradhar PADALA